EMERGENT BIOSOLUTIONS INC. Inventory, LIFO Reserve, Period Charge
EMERGENT BIOSOLUTIONS INC. (EBS) reported Inventory, LIFO Reserve, Period Charge of $41.50 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2023-12-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReservePeriodCharge · last filed 2023-12-11
- EMERGENT BIOSOLUTIONS INC. inventory, lifo reserve, period charge for the quarter ending 2020-09-30 was $13.80M.
- EMERGENT BIOSOLUTIONS INC. inventory, lifo reserve, period charge for fiscal 2021 was $41.50M, a 139.88% increase from fiscal 2020.
- EMERGENT BIOSOLUTIONS INC. inventory, lifo reserve, period charge for fiscal 2020 was $17.30M.
| Period end | Inventory, LIFO Reserve, Period Charge 3 month | Inventory, LIFO Reserve, Period Charge 12 month |
|---|---|---|
| 2021-12-31 | $41.50M 10-K/A · filed 2023-12-11 | |
| 2020-12-31 | $17.30M 10-K · filed 2021-02-19 | |
| 2020-09-30 | $13.80M 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |